DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09

Medical Disclaimer

TopGLP1Providers publishes pricing and program-structure information. It does not provide medical advice, diagnosis, or treatment, and nothing on this site is a substitute for the judgment of a licensed clinician who knows your history.

GLP-1 receptor agonists — tirzepatide and semaglutide in all forms — are prescription medications with real contraindications, interactions, and side effects, including uncommon serious ones described in the FDA-approved labeling for the brand products. Compounded versions are not FDA-approved: they have not been reviewed by the FDA for safety, effectiveness, or manufacturing quality, and since 2025 they are lawful only as patient-specific 503A prescriptions with documented clinical need. Descriptions of standard titration schedules on this site are reports of public labeling and common practice, not dosing recommendations. Do not start, stop, or change any medication based on anything you read here; bring the numbers to a prescriber and let the clinical decision happen where it belongs. If you experience a medical emergency, call 911. To report a suspected problem with any medication, use the FDA MedWatch program.